BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6071101)

  • 1. Inhibitor of blood clotting derived from prothrombin.
    Marciniak E; Murano G; Seegers WH
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):161-6. PubMed ID: 6071101
    [No Abstract]   [Full Text] [Related]  

  • 2. A kinetic approach to the effect of prothrombin concentration on the rate of fibrin polymerization.
    Forsyth G; Brant D; Johnson BC
    Arch Biochem Biophys; 1969 Oct; 134(1):1-7. PubMed ID: 5345585
    [No Abstract]   [Full Text] [Related]  

  • 3. The clotting of the blood of an amphibian, Bufo marinus Linn. 1. Prothrombin-thrombin and "fibrinogen-fibrin" stages.
    HACKETT E; LEPAGE R
    Aust J Exp Biol Med Sci; 1961 Feb; 39():57-65. PubMed ID: 13710284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood].
    Kotschy M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):426-36. PubMed ID: 4121336
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin gel formation in a shear flow.
    Guy RD; Fogelson AL; Keener JP
    Math Med Biol; 2007 Mar; 24(1):111-30. PubMed ID: 17018571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the clotting curves of complex dynamic rigidity for fibrinogen-thrombin solutions.
    Kaibara M; Fukada E
    Biorheology; 1980; 17(3):255-9. PubMed ID: 7213992
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
    Chandra S; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood clotting in nonhuman primates.
    Seaman AJ; Malinow MR
    Lab Anim Care; 1968 Feb; 18(1):80-4. PubMed ID: 4230586
    [No Abstract]   [Full Text] [Related]  

  • 9. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
    Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
    Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.
    Okwusidi JI; Anvari N; Ofosu FA
    J Lab Clin Med; 1993 Jan; 121(1):64-70. PubMed ID: 8426082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheology of blood coagulation.
    Kaibara M
    Biorheology; 1996; 33(2):101-17. PubMed ID: 8679959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of inhibition of the action of thrombin by the fibrinopeptides formed during the clotting of fibrinogen.
    Silver A; Murray M
    Thromb Diath Haemorrh; 1966 Jul; 16(1):277-95. PubMed ID: 6011260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
    Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
    C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
    [No Abstract]   [Full Text] [Related]  

  • 16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of some antineoplastic drugs on inhibiting thrombin catalizing fibrinogen clotting in vitro.
    Lu D; Cao J; Huang Y; Gong L; Chen X; Chen E; Xu B
    Chin Med J (Engl); 1999 Nov; 112(11):1052-3. PubMed ID: 11721472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theories of blood coagulation.
    Riddel JP; Aouizerat BE; Miaskowski C; Lillicrap DP
    J Pediatr Oncol Nurs; 2007; 24(3):123-31. PubMed ID: 17475978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.